➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Johnson and Johnson
Dow
McKinsey
Baxter

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

VINCRISTINE SULFATE PFS Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Vincristine Sulfate Pfs patents expire, and what generic alternatives are available?

Vincristine Sulfate Pfs is a drug marketed by Hospira and Teva Pharms Usa and is included in two NDAs.

The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vincristine sulfate profile page.

Drug patent expirations by year for VINCRISTINE SULFATE PFS
Recent Clinical Trials for VINCRISTINE SULFATE PFS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Acrotech BiopharmaPhase 2
David Rizzieri, MDPhase 2
Mayo ClinicPhase 1

See all VINCRISTINE SULFATE PFS clinical trials

Pharmacology for VINCRISTINE SULFATE PFS
Drug ClassVinca Alkaloid

US Patents and Regulatory Information for VINCRISTINE SULFATE PFS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira VINCRISTINE SULFATE PFS vincristine sulfate INJECTABLE;INJECTION 071484-001 Apr 19, 1988 AP RX No Yes   Start Trial   Start Trial   Start Trial
Teva Pharms Usa VINCRISTINE SULFATE PFS vincristine sulfate INJECTABLE;INJECTION 075493-001 Sep 1, 1999 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
McKesson
Boehringer Ingelheim
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.